Bristol-Myers Squibb Company
Cyclohexyl acid isoxazole azines as LPA antagonists
Last updated:
Abstract:
The present invention provides compounds of Formula (Ia) or (Ib): (Ia) or (Ib), or a stereoisomer, tautomer, or pharmaceutically acceptable salt or solvate thereof, wherein all the variables are as defined herein. These compounds are selective LPA receptor inhibitors. ##STR00001##
Status:
Grant
Type:
Utility
Filling date:
18 Dec 2018
Issue date:
3 May 2022